Enter assignee name

CIPO Patents = 5

EPO Patents = 2

Forward Citations = 696

Loading Chart...

8 inventors (with patents filed for the assignee):

Anton-Lewis Usala (9 out of 15 patents)

Richard Chris Klann (4 out of 16 patents)

Francis Vincent Lamberti (2 out of 15 patents)

4. Ronald Stewart Hill (2 out of 13 patents)

5. Francis V Lamberti (0 patent)

6. Francis V Lamberti (0 patent)

12 patents: Sort by Forward Citations

1. 8053423 - Method of preparing cross-linked bioactive hydrogel matrices (2011-11-08),

2. 7700660 - Method of treating chronic ulcers (2010-04-20),

3. 7303814 - Immobilized bioactive hydrogel matrices as surface coatings (2007-12-04),

4. 6992062 - Method of stimulation hair growth (2006-01-31),

5. 6730315 - Medium and matrix for long-term proliferation of cells (2004-05-04),

6. 6713079 - Methods for increasing vascularization and promoting wound healing (2004-03-30),

7. 6270977 - Specific, highly sensitive, nested PCR detection scheme for the pseudorabies virus (2001-08-07),

8. 5834005 - Bioartificial devices and cellular matrices therefor (1998-11-10),

9. 5830492 - Bioartificial devices and cellular matrices therefor (1998-11-03),

10. 5824331 - Bioartificial devices and cellular matrices therefor (1998-10-20),

11. 5776324 - Electrochemical biosensors (1998-07-07),

12. 5614205 - Bioartificial endocrine device (1997-03-25),

Encelle, Inc. is a biotechnology company specializing in regenerative medicine and tissue engineering. With a focus on developing innovative cell therapies, Encelle is committed to improving patient outcomes and advancing the field of regenerative medicine. The company's unique technology platform allows for the production of customizable cell-based products for various medical applications.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

12 Patents

#9 in Greenville, NC

#542 in North Carolina

#24,779 in US

#46,665 in the World

Greenville, NC, United States of America

Encelle, Inc.